Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol for fibrobronchoscopy sedation in elderly patients
ChiCTR2200065438Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of the University of South China
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of remimazolam in None (2 arms), sponsored by The First Affiliated Hospital of the University of South China. Primary endpoints: Sedation depth (MOAA/S scale), Recovery status (Aldrete score) and 4 more. Planned start Nov 2022; status: not yet recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2200065438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200065438.